Many thanks for sharing your great find. Hope BH knows this topic. They are capable to conduct further research confirm the initial conclusion. The Chinese needs to know it can increase their lifespan and Fruitflow will fly in the sky without any limits.
It seems there is no post from you regarding the latest RNS. What is your view about it? Will it be block buster or just another spoon feed to get the life of SAR a bit longer.
Many thanks for your thoughtful post about 1801. Just a bit curios if 1801 is so big then why nobody is showing interest to snap the whole company in one go. In that way they can get 1801, 1802, 737 and Skill platform. Probably there must some thoughtful explanation about the matter.
A 1-share order that executes would alert a trader that newly discovered liquidity is available at a specific price. Regardless of technique, 1-share trades are likely not used to fill a large position, but rather to learn about market conditions.
Just a matter of interest, why they are buying FF from Indena not PXS. Does it mean PXS gave them the license to sell FF on behalf of PXS or something else? Any thought about the matter will be very much appreciated.
Deucravacitinib at multiple doses did not demonstrate significant clinical benefit vs placebo in moderately to severely active Crohn’s disease or ulcerative colitis. Deucravacitinib was safe and well tolerated.
Does it mean that Deucravacitinib is not good enough for it's intended treatment purpose?
Dear investors! The company is committed to expanding and strengthening its main business, and will make prudent decisions on investment and mergers and acquisitions based on market conditions and overall strategic planning. Thank you for your attention.
Very interesting the word "acquisitions". Probably something is on-going between PXS and BH